CF(17)iPS6

General

Cell Line

hPSCreg name MHHi005-A
Cite as:
MHHi005-A (RRID:CVCL_VE60)
Alternative name(s)
CF(17)iPS6
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
MHHi003-A
(CF(15)iPS10)
Donor diseases:
Cystic fibrosis
MHHi004-A
(CF(16)iPS1)
Donor diseases:
Cystic fibrosis
RCMGi004-A
(P6L2)
Donor diseases:
Cystic Fibrosis
RCMGi001-A
(P1L5)
Donor diseases:
Cystic Fibrosis
RCMGi005-B
(P5L5)
Donor diseases:
Cystic Fibrosis
RCMGi013-A
(P2L2)
Donor's gene variants:
CFTR
Donor diseases:
Cystic Fibrosis
MUBi002-A
(CF 001)
Donor diseases:
Cystic fibrosis
RCMGi005-A
(P5L1)
Donor diseases:
Cystic Fibrosis
RCMGi004-B
(P6L8)
Donor diseases:
Cystic Fibrosis
RCMGi002-A
(P7L2)
Donor diseases:
Cystic Fibrosis
KCLe003-A
(KCL-003-CF-1)
Donor diseases:
Cystic fibrosis
TNRMCi001-A
(iTAF32)
Donor's gene variants:
CFTR
Donor diseases:
Cystic fibrosis
ULBe004-A
(ERAMUC-1)
Donor diseases:
Cystic Fibrosis
RCMGi008-A
(P9L1)
Donor diseases:
Cystic Fibrosis
MHHi002-A
(CF(1)iPS5)
Donor diseases:
Cystic fibrosis
IGGi002-A
Donor diseases:
Cystic Fibrosis
RGIe156-A
(SI-257)
Donor diseases:
Cystic fibrosis
RCMGi007-A
(P8L2)
Donor diseases:
Cystic Fibrosis
INSRMe008-A
(STR-I-203-CFTR)
Donor diseases:
Cystic fibrosis
INSRMe009-A
(STR-I-251-CFTR)
Donor diseases:
Cystic fibrosis
HADe002-A
(HAD 2)
Donor diseases:
Cystic fibrosis
VUBe004-A
(VUB04_CF)
Donor diseases:
Cystic fibrosis
WTSIi420-A
(HPSI0914i-tifo_2)
Donor diseases:
Bardet-Biedl syndrome
WTSIi420-B
(HPSI0914i-tifo_1)
Donor diseases:
Bardet-Biedl syndrome
Last update 22nd May 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Hannover Medical School (MHH)

External Databases

BioSamples SAMEA103885565
Cellosaurus CVCL_VE60
Wikidata Q54905559

General Information

* Is the cell line readily obtainable for third parties?
No
Subclones

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Cystic fibrosis, F508del homozygous
Synonyms
  • Mucoviscidosis
  • CF

External Databases (Donor)

BioSamples SAMEA103885566

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Please provide contact information of the holder of the original Donor Information Sheet.
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please provide the contact information
Alternatives to consent
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Details on restriction to research project
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Please describe how access is provided:
Contact data, institution, or website:
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? MHH Ethikkommission
Approval number
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? MHH Ethikkommission
Approval number
Please describe:
Further constraints on use
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Constraints for use or distribution

hIPSC Derivation

General

Source cell type
A leukocyte with a single non-segmented nucleus in the mature form.
Synonyms
  • mononuclear leukocyte
  • peripheral blood mononuclear cell
Source cell type (free text) CD34 positive cels from peripheral blood

Reprogramming method

Vector type Integrating
Vector Virus (Lentivirus)
Is the used vector excisable?
Unknown
Absence of reprogramming vector(s)?
Unknown
Reprogramming vectors silenced?

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Other medium:
Base medium: DMEM
Main protein source: Knock-out serum replacement
Serum concentration: 20 %

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
SOX2
Yes
SSEA-3
Yes
SSEA-4
Yes
TRA 1-60
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
AFP
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
Desmin
Yes
Neuron
Ont Id: CL_0000540
In vitro spontaneous differentiation
Marker Expressed
TUBB3
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
ongoing

Other Genotyping (Cell Line)